Advanced Biomed Inc. (ADVB) vs Inotiv, Inc. (NOTVQ)

Advanced Biomed Inc. and Inotiv, Inc. are both Diagnostics & Research companies. Advanced Biomed Inc. is the larger, with a market value of $10.4M against $2.8M — 3.7× the size. Inotiv, Inc. has negative trailing earnings, so its P/E is not meaningful; Advanced Biomed Inc. trades at 1.3×. Advanced Biomed Inc. has the higher net margin (0.00% vs −17.1%) and the lower return on invested capital (−29.3% vs −6.19%). Across the 13 metrics below, Advanced Biomed Inc. leads on 10 and Inotiv, Inc. on 3.

Valuation

Metric ADVB NOTVQ Diagnostics & Research median
P/E 1.35 n/m 33.95
P/S n/m 0.00 4.87
P/B 0.91 0.00 3.12
Price to free cash flow n/m n/m 34.02
EV/EBITDA n/m 60.99 25.20
EV/Sales n/m 1.57 5.66
Earnings yield 74.15% (25,300.00%) (1.75%)
Free cash flow yield (35.24%) (2,858.05%) (0.13%)

Profitability

Metric ADVB NOTVQ Diagnostics & Research median
Gross margin — 22.94% 50.89%
Operating margin 0.00% (9.48%) (8.57%)
Net margin 0.00% (17.14%) (6.37%)
Free cash flow margin 0.00% (1.95%) 0.00%
Return on equity 79.17% (74.09%) (2.92%)
Return on assets 55.78% (11.85%) (6.71%)
Return on invested capital (29.27%) (6.19%) 0.00%

Growth

Metric ADVB NOTVQ Diagnostics & Research median
Revenue growth (TTM) — 5.61% 7.69%
EPS growth (last fiscal year) (15.01%) 49.64% —
Revenue growth, 5-year CAGR — 53.36% 7.40%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric ADVB NOTVQ Diagnostics & Research median
Debt to equity 0.00 5.49 0.11
Current ratio 7.38 0.27 2.02
Net debt to EBITDA 1.08 12.68 0.78

Dividend

Metric ADVB NOTVQ Diagnostics & Research median
Dividend yield — — 0.70%
Payout ratio — 0.00 0.00

Size

Metric ADVB NOTVQ Diagnostics & Research median
Market cap 10.42m 2.79m 2.56b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack